During the past decade, Medical Research Center conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 14 clinical trials were completed, i.e. on average, 51.9% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 9 clinical trials were completed. i.e. 64.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Research Center" #1 sponsor was "Pfizer" with 6 trials, followed by "GTx" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "AEON Biopharma, Inc." with 2 trials sponsored and "Astellas Pharma Global Development, Inc." with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Research Center" #1 collaborator was "PPD" with 3 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "IQVIA Pvt. Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Medical Research Center" are "Cardiovascular Disease" (3 trials), "Rheumatoid Arthritis" (3 trials), "Stress Urinary Incontinence" (3 trials), "Atopic Dermatitis" (2 trials) and "Covid19" (2 trials). Many other conditions were trialed in "Medical Research Center" in a lesser frequency.

Most popular intervention types in "Medical Research Center" are "Drug" (30 trials), "Biological" (2 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "ABP-450" (2 trials), "GTx-024" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "fezolinetant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medical Research Center" are 25 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Research Center". undefined are not yet recruiting, 9 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in Medical Research Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Research Center, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".